← Back to Search

Behavioral Intervention

Meditation for Migraine

N/A
Recruiting
Research Sponsored by Maharishi International University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female by birth
Diagnosis of migraine with or without aura, based on ICHD3 criteria
Must not have
Medication overuse headache (MOH)
> 55 years old or < 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how Transcendental Meditation affects the intensity and frequency of migraines in women. It will involve 30 female participants from migraine treatment facilities and support groups in the US.

Who is the study for?
This trial is for women who frequently experience migraines and are seeking alternative treatments. Participants will be selected from migraine treatment centers and support groups within the US.
What is being tested?
The study is testing the Transcendental Meditation® Technique to see if it can reduce the intensity and frequency of migraines in a small group of 30 participants.
What are the potential side effects?
Since this intervention involves meditation, there are no direct medical side effects expected. However, individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female by birth.
Select...
I have been diagnosed with migraine, with or without aura.
Select...
I have had migraines for over a year, starting before I turned 50.
Select...
I am between 18 and 55 years old.
Select...
I experience 6 to 14 migraine days each month.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I suffer from headaches due to overusing medication.
Select...
I am either older than 55 or younger than 18.
Select...
I do not have any major illness or mental health condition that needs urgent treatment.
Select...
I am not willing to keep my migraine medication doses the same.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Frequency and functionality

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exploring the Effect of the Transcendental Meditation® Technique on MigraineExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meditation
2021
Completed Phase 3
~2940

Find a Location

Who is running the clinical trial?

Maharishi International UniversityLead Sponsor
12 Previous Clinical Trials
1,732 Total Patients Enrolled
Dr. Fred T Travis, PhDStudy ChairMaharishi International University
~20 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top